Global DNA demethylation is a hallmark of embryonic epigenetic reprogramming. Yet, mammalian embryos engage non-canonical DNA methylation-maintenance mechanisms to ensure inheritance of exceptional epigenetic germline features to the soma. Besides the paradigmatic genomic imprints these exceptions remain ill-defined and the mechanisms ensuring demethylation resistance in the light of global reprogramming remain poorly understood. Here we will report how the TRIM28 complex protects genomic imprints from aberrant demethylation during early epigenetic reprogramming. We will further describe how other, non-imprinted genes use this machinery to resist DNA demethylation. In particular, we show that the Y-linked gene Rbmy1a1 is highly methylated in mature sperm and resists DNA demethylation post-fertilization. Aberrant hypomethylation of the Rbmy1a1 promoter results in its ectopic activation causing male-specific periimplantation lethality. Rbmy1a1 is thus a novel target of the TRIM28 complex, which is required to protect its repressive epigenetic state during embryonic epigenetic reprogramming. Insights into the regulation of cell fate decisions in developing embryos may lead to improved methods to derive specific cell types for therapeutic purposes, including skeletal muscle cells. The musclespecific microRNA (myomiR), miR-133, is pivotal for specification of the myogenic lineage; however, the detailed mechanisms by which it exerts its effects remain to be elucidated. We determined the genome-wide effects of miR-133 knockdown (KD) in developing somites, the embryonic source of skeletal muscle, using differential transcriptomics. In addition to negative effects on the key myogenic regulatory factors (MRFs), Myf5 and MyoD, this revealed extensive down-regulation of Sonic hedgehog (Shh) pathway components, including patched receptors (Ptch1 and Ptch2), Hedgehog interacting protein (HHIP) and the transcriptional activator, Gli1. Amongst the de-repressed genes following KD of miR-133 was Gli3, which acts predominantly as a transcriptional repressor and is normally excluded from the myotome, which develops into skeletal muscle. A site in the Gli3-3'UTR was confirmed as a direct target for miR-133 by luciferase reporter assays. A detailed phenotypic analysis of miR-133 KD somites revealed that miR-133 is necessary for cell proliferation and extracellular matrix (ECM) deposition. Loss of miR-133 function led to impaired somite growth and the failure to form and maintain the myotome. It also affected the differentiation of the sclerotome. Together, our data suggests that negative regulation of Gli3R expression by miR-133 enables continued Shh pathway activity, which is critical for somite differentiation and, in particular, myogenesis. Consistent with this, injection of purmorphamine, an activator of the Shh pathway, partially rescued the miR-133 KD phenotype and restored myogenesis. We therefore propose a novel Shh-MRF-miR-133 regulatory network that intimately connects the morphogenesis of the myotome with the activation of the myogenic programme. Inversion and chromosomal translocation potentially create a new configuration of cis-regulatory elements (CREs) and its targeting coding sequences, and thereby evoke novel gene regulation. A mouse old mutation named "Hammer toe (Hm)", which exhibits syndactyly, serves as a good example of acquisition of a new gene expression by genome rearrangement. A map-base cloning of the causative genomic region revealed that there is chromosomal translocation of a 150kb DNA fragment in Chr14 to upstream of Sonic hedgehog (Shh) locus in Chr5. We found that this translocated fragment contains no coding sequence, and Shh is ectopically expressed at interdigital region in the Hm mutant. The syndactyly could be caused by the ectopic Shh expression, which is likely elicited by a new CRE in the translocated fragment. This was confirmed by the fact that the syndactyly phenotype was not observed when the translocation was placed at a cis-position relative to a Shh knockout allele, and that the syndactyly was completely abrogated by removal of the translocated fragment by CRISPR/Cas9-mediated genome edition.
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Notably, the genome edition unexpectedly induced an inversion of the translocated fragment. It elevated level of the ectopic Shh expression, and as a consequence enhanced the syndactyly phenotype. Moreover, the inversion increased muscle volume in the autopod, caused cleft palate and led to neonatal lethality. These severe phenotypes were never seen in the original Hm mutant. Thus, the CRE in the translocated fragment changed its gene regulatory activity in an orientation-dependent manner.
In conclusion, the Hm mutation provides a useful model system to study how organisms create a novel gene regulation by acquisition of new CREs via genome rearrangements, and generate a morphological novelty.
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The three-dimensional organization of a genome plays a key role in gene regulation. Recent studies have revealed that chromatin is folded in a hierarchical manner, and that chromosomes are spatially partitioned into megabase-scale and sub-megabase scale domains, compartments and topologically associating domains (TADs), respectively. However, during animal development, when and how this chromatin organization is established is largely unknown.
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